title: [Inborn errors of metabolism as rare diseases with a specific global situation].
abstract: So-called congenital metabolic diseases (CMD) are a consequence of biochemical alterations originating in the genes that result in the alteration of a protein. Depending on this protein's function - whether as an enzyme, a hormone, a receiver-transporter of a cellular membrane or forming part of a cellular organelle (lysosome, peroxysome) - different groups of diseases emerge, which cause the most outstanding characteristic of inborn errors of metabolism (IEM): their clinical heterogeneity. The majority of these diseases are autosomal recessive, with a limited number of asymptomatic carriers, but there are also those ruled by an autonomous, dominant character inheritance or linked to the X chromosome. Taken individually, CMDs are highly infrequent, but taken as a whole CMDs (of which over 500 have been described to date) can affect 1/500 of the newborn. A common characteristic of many CMDs is the possibility of dietary treatment and treatment with enzymatic replacement. For essentially didactic purposes the following groups should be considered: CMDs of the intermediary metabolism (whose types are intoxication and energy deficit), CMDs of cellular organelles, complex CMDs due to cycle alterations and others. A summary is presented of the clinical, diagnostic and therapeutic aspects of one disease of each type of those previously described: hyperphenylalaninemias, deficiencies of the mitochondrial oxidative phosphorilation (OXPHOS) and lysosomal storage diseases.
authors.affiliation: Unidad de Metabolismo, Hospital de Cruces, Baracaldo, 48903, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Sanjurjo
authors.forename: A
authors.initials: A
authors.lastname: Baldellou
authors.forename: K
authors.initials: K
authors.lastname: Aldámiz-Echevarría
authors.forename: M
authors.initials: M
authors.lastname: Montejo
authors.forename: Mc
authors.initials: M
authors.lastname: García Jiménez
mesh_terms: D006801:Humans; D016464:Lysosomal Storage Diseases / Q000175:diagnosis / Q000628:therapy; D008661:Metabolism, Inborn Errors / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D028361:Mitochondrial Diseases / Q000175:diagnosis / Q000628:therapy; D010661:Phenylketonurias / Q000175:diagnosis / Q000628:therapy; D035583:Rare Diseases